CMS Open Payments · Program Year 2024
Carbofix Orthopedics Inc
Carbofix Orthopedics Inc reported $49,695.82 across General Payments, Research, and Ownership to 182 physicians and teaching hospitals across 182 transactions.
- $49.7K
- All-tracks total
- 182
- Transactions
- 182
- Recipients
- −$29.6K
- General Payments vs PY2023
Carbofix Orthopedics Inc reported $49,695.82 across all CMS Open Payments tracks (General + Research + Ownership) to 182 physicians and teaching hospitals in Program Year 2024 - ranking #1350 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $49,695.82, averaging $273.05 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carbofix-orthopedics-inc Carbofix Orthopedics Inc
$49.7K · #1350/1,925 · 0.0% industry · PY2024
- TOT $49.7K
- RANK #1350
- SHARE 0.0%
- TXN 182
- RCP 182
- CAT 5
- GEN $49.7K
- ΔGEN −$29.6K
- TOP1 50.5%
- PY 2024
Volume peers
Nearest volume peer: Bolder Surgical, LLC ($49.7K)
Carbofix Orthopedics Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carbofix Orthopedics Inc's CMS-reported General Payments decreased by $29.6K (−37.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARBOFIX ORTHOPEDICS INCPY2023: CARBOFIX ORTHOPEDICS INCPY2024: Carbofix Orthopedics Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $79,327.29
- PY2024
- $49,695.82
What the Data Shows for Carbofix Orthopedics Inc
Rank #1350 of 1,925 companies in CMS Open Payments for 2024 belongs to Carbofix Orthopedics Inc, which reported $49,695.82 across 182 transactions to 182 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $273.05 per transaction and $273.05 per recipient.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Gift" at $25.0K, accounting for 50.3% of this company's General Payments and 1 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, Carbofix Orthopedics Inc's largest category was "Gift" at $25.0K - 50.3% of General Payments.
Carbofix Orthopedics Inc reports 5 general-payment categories - the top three are Gift (50.3%), Food and Beverage (28.8%), and Consulting Fee (12.6%). The remaining 2 categories make up 8.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Carbofix Orthopedics Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Gift | $25.0K | 1 | 50.3% |
| Food and Beverage | $14.3K | 165 | 28.8% |
| Consulting Fee | $6.3K | 12 | 12.6% |
| Travel and Lodging | $2.9K | 2 | 5.9% |
| Education | $1.2K | 2 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $36,061.21 (72.6%) of $49,695.82 in this company's General Payments records across 119 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carbofix Orthopedics Inc
The five named recipients with the highest reported General Payments from this company
- 1
Santiago Andres Lozano Calderon
$25,094.33 across 3 reported transactions
- 2
BRUCE JOSEPH ZIRAN Jr
$6,008.17 across 13 reported transactions
- 3
John Alexander Abraham
$1,825.44 across 2 reported transactions
- 4
Howard J Goodman
$1,762.95 across 3 reported transactions
- 5
Daniel Christopher Allison
$1,370.32 across 9 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carbofix Orthopedics Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carbofix Orthopedics Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carbofix Orthopedics Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
American Medical & Dental Supplies,Inc.
Modulated Imaging, Inc.
Solco Biomedical Co., Ltd.
Foundation Medical, Llc
Naviswiss, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.